Poxel S.A. – LSE:0RA2.L
Poxel S.A. stock price today
Poxel S.A. key metrics
Market Cap | 38.54M |
Enterprise value | N/A |
P/E | N/A |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | N/A |
Price/Book | N/A |
PEG ratio | N/A |
EPS | N/A |
Revenue | 2.65M |
EBITDA | -4.30M |
Income | N/A |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | -162.26% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freePoxel S.A. stock price history
Poxel S.A. stock forecast
Poxel S.A. financial statements
| Jun 2022 | 83K | -13.40M | -16145.78% |
|---|---|---|---|
| Dec 2022 | 591K | -17.99M | -3045.18% |
| Jun 2023 | 955K | -26.24M | -2747.96% |
| Dec 2023 | 1.02M | 0 |
| Sep 2022 | 34714000 | 52.95M | 152.55% |
|---|---|---|---|
| Dec 2022 | 34714000 | 52.95M | 152.55% |
| Jun 2023 | 12807000 | 54.69M | 427.06% |
| Dec 2023 | 0 | 0 |
| Jun 2022 | -13.30M | -70K | -2.77M |
|---|---|---|---|
| Dec 2022 | -9.55M | 55K | 6.41M |
| Jun 2023 | -9.21M | 7K | 3.75M |
| Dec 2023 | 0 | 0 | 0 |
Poxel S.A. alternative data
| Aug 2023 | 37 |
|---|---|
| Sep 2023 | 37 |
| Oct 2023 | 15 |
| Nov 2023 | 15 |
| Dec 2023 | 15 |
| Jan 2024 | 15 |
| Feb 2024 | 15 |
| Mar 2024 | 15 |
| Apr 2024 | 15 |
| May 2024 | 15 |
| Jun 2024 | 15 |
| Jul 2024 | 15 |
Poxel S.A. other data
-
What's the price of Poxel S.A. stock today?
One share of Poxel S.A. stock can currently be purchased for approximately $1.6.
-
When is Poxel S.A.'s next earnings date?
Unfortunately, Poxel S.A.'s (0RA2.L) next earnings date is currently unknown.
-
Does Poxel S.A. pay dividends?
No, Poxel S.A. does not pay dividends.
-
How much money does Poxel S.A. make?
Poxel S.A. has a market capitalization of 38.54M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 193.92% to 1.98M US dollars.
-
What is Poxel S.A.'s stock symbol?
Poxel S.A. is traded on the LSE under the ticker symbol "0RA2.L".
-
What is Poxel S.A.'s primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of Poxel S.A.?
Shares of Poxel S.A. can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does Poxel S.A. have?
As Jul 2024, Poxel S.A. employs 15 workers.
-
When Poxel S.A. went public?
Poxel S.A. is publicly traded company for more then 9 years since IPO on 3 Feb 2016.
-
What is Poxel S.A.'s official website?
The official website for Poxel S.A. is poxelpharma.com.
-
How can i contact Poxel S.A.?
Poxel S.A. can be reached via phone at +33 4 37 37 20 10.
Poxel S.A. company profile:
Poxel S.A.
poxelpharma.comLSE
6
Biotechnology
Healthcare
Poxel S.A., a clinical-stage biopharmaceutical company, develops novel treatments for metabolic diseases, type 2 diabetes, and liver diseases. The company's lead product is TWYMEEG (Imeglimin), an oral drug candidate that targets mitochondrial dysfunction and approved for the treatment of type 2 diabetes in Japan. It also develops PXL770, an adenosine monophosphate-activated protein kinase enzyme, which is in a Phase 2a clinical trial that treats chronic metabolic diseases, including diseases that affect the liver, such as non-alcoholic steatohepatitis (NASH). Poxel S.A. has a licensing agreement with Enyo Pharma S.A.S. for the development of farnesoid X receptor that is in Phase 2a study for the treatment of hepatitis B and NASH; and DeuteRx LLC for the development of PXL065, a mitochondrial pyruvate carrier inhibitor, which is in a phase I clinical trial for the treatment of NASH. The company was incorporated in 2009 and is headquartered in Lyon, France.
Lyon, 69007
:
:
:
